The DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
Neuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients With Cancer
Open accessAbstract
Patients with cancer experience a host of behavioral alterations that include depression, fatigue, sleep disturbances, and cognitive dysfunction. These behavioral comorbidities are apparent throughout the process of diagnosis and treatment for cancer and can persist well into the survivorship period. There is a rich literature describing potential consequences of behavioral comorbidities in patients with cancer including impaired quality of life, reduced treatment adherence, and increased disease-related morbidity and mortality. Medical complications of cancer and its treatment such as anemia, thyroid dysfunction, and the neurotoxicity of cancer chemotherapeutic agents account in part for these behavioral changes. Nevertheless, recent advances in the neurosciences and immunology/oncology have revealed novel insights into additional pathophysiologic mechanisms that may significantly contribute to the development of cancer-related behavioral changes. Special attention has been focused on immunologic processes, specifically activation of innate immune inflammatory responses and their regulation by neuroendocrine pathways, which, in turn, influence CNS functions including neurotransmitter metabolism, neuropeptide function, sleep-wake cycles, regional brain activity, and, ultimately, behavior. Further understanding of these immunologic influences on the brain provides a novel conceptual framework for integrating the wide spectrum of behavioral alterations that occur in cancer patients and may reveal a more focused array of translational targets for therapeutic interventions and future research. Such developments warrant complementary advances in identification of cancer patients at risk as well as those currently suffering, including an increased emphasis on the status of behavior as a “sixth vital sign” to be assessed in all cancer patients throughout their disease encounter.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
Impact of sleep debt on metabolic and endocrine function
Spiegel, K., Leproult, R., & Van Cauter, E. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01376-8 · Cited by 3,668
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Self-citationCausal Relationship Between Stressful Life Events and the Onset of Major Depression
Kendler, K. S., Karkowski, L. M., & Prescott, C. A. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.6.837 · Cited by 2,566
Clinical application of C-reactive protein for cardiovascular disease detection and prevention
Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000053730.47739.3c · Cited by 2,513 · cited 1×
“Moreover, in the case of hsCRP, cutoff values have been established that have both predictive validity and categorization of risk in relation to disease outcome in cardiovascular disorders.(115) Given the fluctuating status of cancer patients during treatment, it is also suggested that longitudinal assessments of both…”
BackgroundRidker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429
Inflammatory Blockade Restores Adult Hippocampal Neurogenesis
Monje, M. L., Toda, H., & Palmer, T. D. (2003) · Science · doi:10.1126/science.1088417 · Cited by 2,426
Fishman, D., Faulds, G., Jeffery, R., Mohamed-Ali, V, Yudkin, J. S., Humphries, S., & Woo, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2629 · Cited by 2,243
Immune-neuro-endocrine interactions: facts and hypotheses.
BESEDOVSKY, H. O., & REY, A. D. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-1-64 · Cited by 1,564
Twenty years of research on cytokine-induced sickness behavior
Dantzer, R., & Kelley, K. W. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.09.006 · Cited by 1,420
Inflammation and cancer: how hot is the link?
Aggarwal, B. B., Shishodia, S., Sandur, S. K., Pandey, M. K., & Sethi, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.029 · Cited by 1,312
Why rejection hurts: a common neural alarm system for physical and social pain
Eisenberger, N. I., & Lieberman, M. D. (2004) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2004.05.010 · Cited by 1,246
Raison, C. L., & Miller, A. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.9.1554 · Cited by 1,197
Self-citationEffect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk
Meier-Ewert, H. K., Ridker, P. M., Rifai, N., Regan, M. M., Price, N. J., Dinges, D. F., & Mullington, J. M. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.07.050 · Cited by 1,195 · cited 1×
“Sleep loss induces cellular and genomic markers of inflammation(28) and leads to increases in circulating levels of innate immune cytokines and markers of systemic inflammation such as C-reactive protein (CRP).(29,30) Conversely, elevations of innate immune cytokines such as IL-6, before sleep onset correlate with pro…”
BackgroundPhysiology and pharmacology of corticotropin-releasing factor.
Owens, M. J., & Nemeroff, C. B. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06673-6 · Cited by 1,142
Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life.
Bower, J. E., Ganz, P. A., Desmond, K. A., Rowland, J. H., Meyerowitz, B. E., & Belin, T. R. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.4.743 · Cited by 1,134 · cited 1×
“Although fatigue typically declines after cancer treatment, there is growing evidence that fatigue may persist for months or years in a significant subpopulation of patients.(58,59)”
BackgroundSelf-citationParoxetine for the prevention of depression induced by high-dose interferon alfa.
Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., Greiner, K., Nemeroff, C. B., & Miller, A. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103293441303 · Cited by 1,120
Self-citationBehavioral and Pharmacological Therapies for Late-Life Insomnia: A Randomized Controlled Trial
Morin, C. M., Colecchi, C., Stone, J., Sood, R., & Brink, D. (1999) · JAMA · doi:10.1001/jama.281.11.991 · Cited by 1,095
Diurnal Cortisol Rhythm as a Predictor of Breast Cancer Survival
Sephton, S. E. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.12.994 · Cited by 1,082
Schmidt, M. I., Duncan, B. B., Sharrett, A. R., Lindberg, G., Savage, P. J., Offenbacher, S., Azambuja, M. I., Tracy, R. P., & Heiss, G. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01046-6 · Cited by 1,071
Adverse Effects of Modest Sleep Restriction on Sleepiness, Performance, and Inflammatory Cytokines
Vgontzas, A. N., Zoumakis, E., Bixler, E. O., Lin, H.-M., Follett, H., Kales, A., & Chrousos, G. P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031562 · Cited by 1,050
The Relationship of Depression and Stressors to Immunological Assays: A Meta-Analytic Review
Zorrilla, E. P., Luborsky, L., McKay, J. R., Rosenthal, R., Houldin, A., Tax, A., McCorkle, R., Seligman, D. A., & Schmidt, K. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2000.0597 · Cited by 995
A mechanism converting psychosocial stress into mononuclear cell activation
Bierhaus, A., Wolf, J., Andrassy, M., Rohleder, N., Humpert, P. M., Petrov, D., Ferstl, R., von Eynatten, M., Wendt, T., Rudofsky, G., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438019100 · Cited by 927
Candidate mechanisms for chemotherapy-induced cognitive changes
Ahles, T. A., & Saykin, A. J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2073 · Cited by 916
Depression and cancer: mechanisms and disease progression
Spiegel, D., & Giese-Davis, J. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00566-3 · Cited by 874
Cytokine-induced sickness behavior: where do we stand?
Dantzer, R. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2000.0613 · Cited by 862
Insomnia in the Context of Cancer: A Review of a Neglected Problem
Savard, J., & Morin, C. M. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.895 · Cited by 861
Sleep Deprivation and Activation of Morning Levels of Cellular and Genomic Markers of Inflammation
Irwin, M. R. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.16.1756 · Cited by 850
Self-citationPace, T. W. W., Mletzko, T. C., Alagbe, O., Musselman, D. L., Nemeroff, C. B., Miller, A. H., & Heim, C. M. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1630 · Cited by 810
Self-citationCytokine‐Induced Sickness Behavior: Mechanisms and Implications
Dantzer, R. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05827.x · Cited by 801
Capuron, L. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00407-9 · Cited by 797
Self-citationCarlson, L. E., Speca, M., Patel, K. D., & Goodey, E. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000074003.35911.41 · Cited by 773
van Dam, F. S. A. M., Boogerd, W., Schagen, S. B., Muller, M. J., Droogleever Fortuyn, M. E., Wall, E. V. D., & Rodenhuis, S. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.3.210 · Cited by 763
Courneya, K. S., Mackey, J. R., Bell, G. J., Jones, L. W., Field, C. J., & Fairey, A. S. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.093 · Cited by 753
Ahles, T. A., Saykin, A. J., Furstenberg, C. T., Cole, B., Mott, L. A., Skalla, K., Whedon, M. B., Bivens, S., Mitchell, T., Greenberg, E. R., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.485 · Cited by 736
Zobel, A. W., Nickel, T., Künzel, H. E., Ackl, N., Sonntag, A., Ising, M., & Holsboer, F. (2000) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(00)00016-9 · Cited by 705
Fatigue in long‐term breast carcinoma survivors: A longitudinal investigation
Bower, J. E., Ganz, P. A., Desmond, K. A., Bernaards, C., Rowland, J. H., Meyerowitz, B. E., & Belin, T. R. (2006) · Cancer · doi:10.1002/cncr.21671 · Cited by 694
Self-citationEricsson, A., Kovacs, K., & Sawchenko, P. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-02-00897.1994 · Cited by 683
Wefel, J. S., Lenzi, R., Theriault, R. L., Davis, R. N., & Meyers, C. A. (2004) · Cancer · doi:10.1002/cncr.20272 · Cited by 679
Cella, D., Davis, K., Breitbart, W., Curt, G., & Coalition, F. T. F. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.14.3385 · Cited by 652
The cholinergic anti-inflammatory pathway
Pavlov, V. A., & Tracey, K. J. (2005) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2005.03.015 · Cited by 622
Pace, T. W. W., Hu, F., & Miller, A. H. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.08.009 · Cited by 621
Self-citationCognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma
Schagen, S. B., van Dam, F. S. A. M., Muller, M. J., Boogerd, W., Lindeboom, J., & Bruning, P. F. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990201)85:3<640::aid-cncr14>3.0.co;2-g · Cited by 620
Espie, C. A. (2002) · Annual Review of Psychology · doi:10.1146/annurev.psych.53.100901.135243 · Cited by 596
Frank, M. G., Baratta, M. V., Sprunger, D. B., Watkins, L. R., & Maier, S. F. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.03.005 · Cited by 578
Cytokines and psychopathology: Lessons from interferon-α
Capuron, L., & Miller, A. H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.009 · Cited by 562 · cited 1×
“associated with the development of major depression in patients with malignant melanoma during IFN- therapy.(18,19)”
Self-citationZhu, C.-B., Blakely, R. D., & Hewlett, W. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301029 · Cited by 549
Fatigue and Proinflammatory Cytokine Activity in Breast Cancer Survivors
Bower, J. E., Ganz, P. A., Aziz, N., & Fahey, J. L. (2002) · Psychosomatic Medicine · doi:10.1097/00006842-200207000-00010 · Cited by 540
Self-citationIrwin, M. R., Cole, J. C., & Nicassio, P. M. (2006) · Health Psychology · doi:10.1037/0278-6133.25.1.3 · Cited by 537
Self-citationDepression in Patients With Cancer: Diagnosis, Biology, and Treatment
McDaniel, J. S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950140007002 · Cited by 534
Cleeland, C. S., Bennett, G. J., Dantzer, R., Dougherty, P. M., Dunn, A. J., Meyers, C. A., Miller, A. H., Payne, R., Reuben, J. M., Wang, X. S., et al. (2003) · Cancer · doi:10.1002/cncr.11382 · Cited by 526
Self-citationFatigue in cancer patients during and after treatment
Servaes, P., Verhagen, C., & Bleijenberg, G. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00332-x · Cited by 498
Interferon-alpha–induced changes in tryptophan metabolism
Capuron, L., Neurauter, G., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., Fuchs, D., & Miller, A. H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00173-2 · Cited by 493
Self-citationMormont, M., Waterhouse, J. M., Bleuzen, P., Giacchetti, S., Jami, A., Bogdan, A., Lellouch, J., Misset, J. L., Touitou, Y., & Lévi, F. (2000) · PubMed · Cited by 486
Home-Based Physical Activity Intervention for Breast Cancer Patients
Pinto, B. M., Frierson, G. M., Rabin, C., Trunzo, J. J., & Marcus, B. H. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.080 · Cited by 460
Meyers, C. A., Albitar, M., & Estey, E. (2005) · Cancer · doi:10.1002/cncr.21234 · Cited by 459
Cognitive Impairment Associated With Chemotherapy for Cancer: Report of a Workshop
Tannock, I. F., Ahles, T. A., Ganz, P. A., & van Dam, F. S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.094 · Cited by 453
Musselman, D. L., Miller, A. H., Porter, M. R., Manatunga, A., Gao, F., Penna, S., Pearce, B. D., Landry, J., Glover, S., McDaniel, J. S., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1252 · Cited by 445
Self-citationBonaccorso, S., Marino, V., Puzella, A., Pasquini, M., Biondi, M., Artini, M., Almerighi, C., Verkerk, R., Meltzer, H., & Maes, M. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200202000-00014 · Cited by 437
Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines
Johnson, J. D., Campisi, J., Sharkey, C. M., Kennedy, S. L., Nickerson, M., Greenwood, B. N., & Fleshner, M. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.090 · Cited by 424
Mechanisms of glucocorticoid receptor signaling during inflammation
Smoak, K. A., & Cidlowski, J. A. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.06.010 · Cited by 420
Psychological, behavioral, and immune changes after a psychological intervention: a clinical trial
Andersen, B. L., Farrar, W. B., Golden-Kreutz, D. M., Glaser, R., Emery, C. F., Crespin, T. R., Shapiro, C. L., & Carson, W. E. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.030 · Cited by 416
Prevalence, Clinical Characteristics, and Risk Factors for Insomnia in the Context of Breast Cancer
Savard, J., Simard, S., Blanchet, J., Ivers, H., & Morin, C. M. (2001) · SLEEP · doi:10.1093/sleep/24.5.583 · Cited by 414 · cited 2×
“longed latency to fall asleep, and increased awake time during the night.(81,82) Even before treatment, patients with cancer have reported significant sleep impairment,(83) and among cancer survivors, sleep”
BackgroundSilverman, D. H. S., Dy, C. J., Castellon, S. A., Lai, J., Pio, B. S., Abraham, L., Waddell, K., Petersen, L., Phelps, M. E., & Ganz, P. A. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9380-z · Cited by 397
Evidence Report on the Occurrence, Assessment, and Treatment of Fatigue in Cancer Patients
Lawrence, D. P. (2004) · Journal of the National Cancer Institute Monographs · doi:10.1093/jncimonographs/lgh027 · Cited by 396
Inflammatory Biomarkers for Persistent Fatigue in Breast Cancer Survivors
Collado-Hidalgo, A., Bower, J. E., Ganz, P. A., Cole, S. W., & Irwin, M. R. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2398 · Cited by 394
Self-citationMethylphenidate therapy improves cognition, mood, and function of brain tumor patients.
Meyers, C. A., Weitzner, M. A., Valentine, A. D., & Levin, V. A. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2522 · Cited by 377
Spath-Schwalbe, E. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.5.1573 · Cited by 373
Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression?
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.8.1189 · Cited by 364
Schubert, C., Hong, S., Natarajan, L., Mills, P. J., & Dimsdale, J. E. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.11.004 · Cited by 364
Gielissen, M. F. M., Verhagen, S., Witjes, F., & Bleijenberg, G. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.8270 · Cited by 349 · cited 1×
“icant improvement in fatigue in 54% of cancer survivors compared with 4% of patients assigned to a control condition.(118) Regarding the”
BackgroundDepression in cancer: new developments regarding diagnosis and treatment
Raison, C. L., & Miller, A. H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00413-x · Cited by 336
Self-citationMorrow, G. R., Hickok, J. T., Roscoe, J. A., Raubertas, R. F., Andrews, P. L. R., Flynn, P. J., Hynes, H. E., Banerjee, T. K., Kirshner, J. J., & King, D. K. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.070 · Cited by 324 · cited 1×
“was found to reduce depression while having limited effect on fatigue.(107,142) On the other hand, preliminary evidence suggests that dopaminergic agents such as the psychostimulant, methylphenidate, may treat fatigue and improve neuropsychological functioning in patients undergoing cancer treatments(143) and patients…”
BackgroundEffects of Cytokines on Cerebral Neurotransmission: Comparison with the Effects of Stress
Dunn, A. J., Wang, J., & Ando, T. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_8 · Cited by 316
Mood and cognitive side effects of interferon-alpha therapy.
Valentine, A. D., Meyers, C. A., Kling, M. A., Richelson, E., & Hauser, P. (1998) · PubMed · Cited by 312
Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy
Pusztai, L., Mendoza, T. R., Reuben, J. M., Martinez, M. M., Willey, J. S., Lara, J., Syed, A., Fritsche, H. A., Bruera, E., Booser, D., et al. (2004) · Cytokine · doi:10.1016/j.cyto.2003.10.004 · Cited by 312
Capuron, L., Raison, C. L., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., & Miller, A. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.7.1342 · Cited by 308
Self-citationDiurnal cortisol rhythm and fatigue in breast cancer survivors
Bower, J. E., Ganz, P. A., Dickerson, S. S., Petersen, L., Aziz, N., & Fahey, J. L. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.06.003 · Cited by 308
Self-citationFatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer
Ancoli-Israel, S., Liu, L., Marler, M. R., Parker, B. A., Jones, V., Sadler, G. R., Dimsdale, J., Cohen-Zion, M., & Fiorentino, L. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-005-0861-0 · Cited by 306
Self-citationANDERSON-HANLEY, C., SHERMAN, M. L., RIGGS, R., AGOCHA, V. B., & COMPAS, B. E. (2003) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617703970019 · Cited by 302
Maier, S. F. (2003) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(03)00032-1 · Cited by 300 · cited 2×
“Although candidate mechanisms of cognitive dysfunction in cancer patients clearly involve a complex interplay of genes, hormones, and the immune system,(106) findings suggest that inflammatory factors may play an important role.(25) For example, a significant negative correlation has been found between plasma IL-6 and…”
Cruess, D. G., Antoni, M. H., McGregor, B. A., Kilbourn, K. M., Boyers, A. E., Alferi, S. M., Carver, C. S., & Kumar, M. (2000) · Psychosomatic Medicine · doi:10.1097/00006842-200005000-00002 · Cited by 298
A Cytokine-Based Neuroimmunologic Mechanism of Cancer-Related Symptoms
Lee, B.-N., Dantzer, R., Langley, K. E., Bennett, G. J., Dougherty, P. M., Dunn, A. J., Meyers, C. A., Miller, A. H., Payne, R., Reuben, J. M., et al. (2004) · Neuroimmunomodulation · doi:10.1159/000079408 · Cited by 294
Self-citationInflammatory Markers and Sleep Disturbance in Major Depression
Motivala, S. J., Sarfatti, A., Olmos, L., & Irwin, M. R. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000149259.72488.09 · Cited by 288
Self-citationMcGregor, B. A., Antoni, M. H., Boyers, A., Alferi, S. M., Blomberg, B. B., & Carver, C. S. (2004) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(03)00036-9 · Cited by 266
Depression in patients with cancer
Mermelstein, H. T., & Lesko, L. (1992) · Psycho-Oncology · doi:10.1002/pon.2960010404 · Cited by 266
Rich, T., Innominato, P. F., Boerner, J., Mormont, M. C., Iacobelli, S., Baron, B., Jasmin, C., & Lévi, F. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2000 · Cited by 259
Sleep restriction alters the hypothalamic-pituitary-adrenal response to stress
Meerlo, P., Koehl, M., Van Der Borght, K., & Turek, F. W. (2002) · Journal of Neuroendocrinology · doi:10.1046/j.0007-1331.2002.00790.x · Cited by 250
Neurological complications of radiotherapy and chemotherapy
Keime-Guibert, F., Napolitano, M., & Delattre, J.-Y. (1998) · Journal of Neurology · doi:10.1007/s004150050271 · Cited by 246
Quesnel, C., Savard, J., Simard, S., Ivers, H., & Morin, C. M. (2003) · Journal of Consulting & Clinical Psychology · doi:10.1037//0022-006x.71.1.189 · Cited by 237
Antoni, M. H., Wimberly, S. R., Lechner, S. C., Kazi, A., Sifre, T., Urcuyo, K. R., Phillips, K., Smith, R. G., Petronis, V. M., Guellati, S., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.10.1791 · Cited by 237
Stanton, A. L., Ganz, P. A., Kwan, L., Meyerowitz, B. E., Bower, J. E., Krupnick, J. L., Rowland, J. H., Leedham, B., & Belin, T. R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.101 · Cited by 236
Self-citationAltered Cortisol Response to Psychologic Stress in Breast Cancer Survivors With Persistent Fatigue
Bower, J. E., Ganz, P. A., & Aziz, N. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000155666.55034.c6 · Cited by 235
Self-citationCognitive behavioural interventions for sleep problems in adults aged 60+
Montgomery, P., & Dennis, J. A. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003161 · Cited by 231
Brown, D. J. F., McMillan, D. C., & Milroy, R. (2005) · Cancer · doi:10.1002/cncr.20777 · Cited by 231
Basal Ganglia Hypermetabolism and Symptoms of Fatigue during Interferon-α Therapy
Capuron, L., Pagnoni, G., Demetrashvili, M. F., Lawson, D. H., Fornwalt, F. B., Woolwine, B., Berns, G. S., Nemeroff, C. B., & Miller, A. H. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301362 · Cited by 229
Self-citationZhu, C.-B., Carneiro, A. M., Dostmann, W. R., Hewlett, W. A., & Blakely, R. D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410858200 · Cited by 228
Anterior Cingulate Activation and Error Processing During Interferon-Alpha Treatment
Capuron, L., Pagnoni, G., Demetrashvili, M., Woolwine, B. J., Nemeroff, C. B., Berns, G. S., & Miller, A. H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.033 · Cited by 222 · cited 2×
“with high-trait anxiety, neuroticism, and obsessive-compulsive disorder.(20) Studies using [(18)F]fluorodeoxyglucose (FDG) and positron”
MethodSelf-citationPsychosocial factors and interleukin-6 among women with advanced ovarian cancer
Costanzo, E. S., Lutgendorf, S. K., Sood, A. K., Anderson, B., Sorosky, J., & Lubaroff, D. M. (2005) · Cancer · doi:10.1002/cncr.21147 · Cited by 217
Kuipers, S. D., & Bramham, C. R. (2006) · PubMed · Cited by 212
Cytokines, “depression due to a general medical condition”, and antidepressant drugs
Yirmiya, R., Weidenfeld, J., Pollak, Y., Morag, M., Morag, A., Avitsur, R., Barak, O., Reichenberg, A., Cohen, E., Shavit, Y., et al. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_16 · Cited by 208
Persistent neurotoxicity of systemically administered interferon‐alpha
Meyers, C. A., Scheibel, R. S., & Forman, A. D. (1991) · Neurology · doi:10.1212/wnl.41.5.672 · Cited by 208
Madhusudan, S., Foster, M., Muthuramalingam, S. R., Braybrooke, J. P., Wilner, S., Kaur, K., Han, C., Hoare, S., Balkwill, F., Talbot, D. C., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0730 · Cited by 205
Jacobsen, P. B., Meade, C. D., Stein, K. D., Chirikos, T. N., Small, B. J., & Ruckdeschel, J. C. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.301 · Cited by 201
Fairey, A. S., Courneya, K. S., Field, C. J., Bell, G. J., Jones, L. W., Martin, B. S., & Mackey, J. R. (2005) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2005.04.001 · Cited by 199
Insomnia and its treatment in women with breast cancer
Fiorentino, L., & Ancoli-Israel, S. (2006) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2006.03.005 · Cited by 197
Self-citationAndersen, B. L., Farrar, W. B., Golden-Kreutz, D., Emery, C. F., Glaser, R., Crespin, T., & Carson, W. E. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.03.005 · Cited by 195
Barrientos, R. M., Sprunger, D. B., Campeau, S., Watkins, L. R., Rudy, J. W., & Maier, S. F. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.06.009 · Cited by 192 · cited 1×
“Of note, stress-induced IL-1 in the brain has been shown to significantly reduce the expression of brain-derived neurotrophic factor (BDNF), which is believed to play a pivotal role in neuronal growth and development, learning, synaptic plasticity, and, ultimately, behavioral disorders.(40,41)”
BackgroundImpaired sleep and rhythms in persons with cancer
Lee, K., Cho, M., Miaskowski, C., & Dodd, M. (2004) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2003.10.001 · Cited by 191
Geinitz, H., Zimmermann, F. B., Stoll, P., Thamm, R., Kaffenberger, W., Ansorg, K., Keller, M., Busch, R., van Beuningen, D., & Molls, M. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01657-1 · Cited by 190
Monk, J. P., Phillips, G., Waite, R., Kuhn, J., Schaaf, L. J., Otterson, G. A., Guttridge, D., Rhoades, C., Shah, M., Criswell, T., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2838 · Cited by 179 · cited 1×
“one study that tolerability of chemotherapy (including reduced fatigue) was improved.(141)”
BackgroundOnitilo, A. A., Nietert, P. J., & Egede, L. E. (2006) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2006.05.006 · Cited by 171
Bower, J. E., Ganz, P. A., Aziz, N., Olmstead, R., Irwin, M. R., & Cole, S. W. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.08.001 · Cited by 168
Self-citationStudy of Etanercept, a Tumor Necrosis Factor-Alpha Inhibitor, in Recurrent Ovarian Cancer
Madhusudan, S., Muthuramalingam, S. R., Braybrooke, J. P., Wilner, S., Kaur, K., Han, C., Hoare, S., Balkwill, F., & Ganesan, T. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.127 · Cited by 167
Evidence-Based Treatment for Cancer-Related Fatigue
Mock, V. (2004) · JNCI Monographs · doi:10.1093/jncimonographs/lgh025 · Cited by 166
Savard, J., Simard, S., Ivers, H., & Morin, C. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.513 · Cited by 165
Greenberg, D. B., Gray, J. L., Mannix, C. M., Eisenthal, S., & Carey, M. (1993) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(93)90127-h · Cited by 160
Fatigue during breast radiotherapy and its relationship to biological factors
Wratten, C., Kilmurray, J., Nash, S., Seldon, M., Hamilton, C. S., O'Brien, P. C., & Denham, J. W. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.10.008 · Cited by 160
T-Cell Homeostasis in Breast Cancer Survivors With Persistent Fatigue
Bower, J. E., Ganz, P. A., Aziz, N., Fahey, J. L., & Cole, S. W. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg0019 · Cited by 153
Self-citationPrefrontal cortical hypometabolism during low-dose interferon alpha treatment
Juengling, F. D., Ebert, D., Gut, O., Engelbrecht, M. A., Rasenack, J., Nitzsche, E. U., Bauer, J., & Lieb, K. (2000) · Psychopharmacology · doi:10.1007/s002130000549 · Cited by 149
Capuron, L., Ravaud, A., & Dantzer, R. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200105000-00007 · Cited by 148 · cited 2×
“slowing) also have been associated with the development of depressive symptoms in cancer patients.(24) Depression”
BackgroundSelf-citationFrank, E. (2007) · Journal of Clinical Psychology · doi:10.1002/jclp.20371 · Cited by 139
Biomarkers of depression in cancer patients
Jehn, C. F., Kuehnhardt, D., Bartholomae, A., Pfeiffer, S., Krebs, M., Regierer, A. C., Schmid, P., Possinger, K., & Flath, B. C. (2006) · Cancer · doi:10.1002/cncr.22294 · Cited by 139
Interferon-Induced Fatigue in Patients With Melanoma: A Pilot Study of Exercise and Methylphenidate
Schwartz, A. L., Thompson, J. A., & Masood, N. (2002) · Oncology nursing forum · doi:10.1188/02.onf.e85-e90 · Cited by 139
Nonpharmacologic group treatment of insomnia: a preliminary study with cancer survivors
Davidson, J. R., Waisberg, J. L., Brundage, M., & MacLean, A. (2001) · Psycho-Oncology · doi:10.1002/pon.525 · Cited by 134
Wang, X., Wu, H., & Miller, A. H. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001339 · Cited by 128
Self-citationMaier, S. F., & Watkins, L. R. (2003) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(02)00079-x · Cited by 125
The days and nights of cancer cells.
Canaple, L., Kakizawa, T., & Laudet, V. (2003) · PubMed · Cited by 123
Mills, P. J., Parker, B. A., Dimsdale, J. E., Sadler, G. R., & Ancoli‐Israel, S. (2005) · Biological Psychology · doi:10.1016/j.biopsycho.2004.11.007 · Cited by 122
Self-citationDimeo, F., Schmittel, A. H., Fietz, T. J., Schwartz, S., Köhler, P., Boning, D. G., & Thiel, E. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh314 · Cited by 116
Interferon-α Stimulates the Hypothalamic- Pituitary-Adrenal Axis in vivo and in vitro
Gisslinger, H., Svoboda, T., Clodi, M., Gilly, B., Ludwig, H., Havelec, L., & Luger, A. (2008) · Neuroendocrinology · doi:10.1159/000126396 · Cited by 111
Disordered Sleep, Nocturnal Cytokines, and Immunity in Alcoholics
Redwine, L., Dang, J., Hall, M., & Irwin, M. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000038943.33335.d2 · Cited by 109
Self-citationDepression in women treated for gynecological cancer: clinical and neuroendocrine assessment
Evans, D. L., McCartney, C. F., Nemeroff, C. B., Raft, D. D., Quade, D., Golden, R. N., Haggerty, J. J., Holmes, V. F., Simon, J. S., & Droba, M. (1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.4.447 · Cited by 109
The relationship between fatigue and light exposure during chemotherapy
Liu, L., Marler, M., Parker, B. A., Jones, V. E., Johnson, S., Cohen‐Zion, M., Fiorentino, L., Sadler, G. R., & Ancoli‐Israel, S. (2005) · Supportive Care in Cancer · doi:10.1007/s00520-005-0824-5 · Cited by 103
Self-citationHolley, S. (2000) · Cancer Practice · doi:10.1046/j.1523-5394.2000.82007.x · Cited by 96
Irwin, M., Rinetti, G., Redwine, L., Motivala, S., Dang, J., & Ehlers, C. (2004) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2004.02.001 · Cited by 95
Self-citationLow neuropsychologic performance among adult cancer survivors treated with chemotherapy
Ferguson, R. J., & Ahles, T. A. (2003) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-003-0081-2 · Cited by 95
Bianchi, R., Brines, M. L., Lauria, G., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2177 · Cited by 94
Weitzner, M. A., Meyers, C. A., & Valentine, A. D. (1995) · Journal of Neuropsychiatry · doi:10.1176/jnp.7.3.347 · Cited by 84
Stemmer, S. M., Stears, J. C., Burton, B. S., Jones, R. B., & Simon, J. H. (1994) · PubMed Central · Cited by 82
High Level of Fatigue in Lymphoma Patients Treated With High Dose Therapy
Knobel, H., Loge, J. H., Nordøy, T., Kolstad, A., Espevik, T., Kvaløy, S., & Kaasa, S. (2000) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(00)00144-5 · Cited by 80
Mills, P. J., Parker, B. A., Jones, V. E., Adler, K. A., Perez, C. J., Johnson, S., Cohen‐Zion, M., Marler, M., Sadler, G. R., Dimsdale, J. E., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0734-04 · Cited by 76
Self-citationFactors Related to Persistent Fatigue Following Completion of Breast Cancer Treatment
Gélinas, C., & Fillion, L. (2004) · Oncology nursing forum · doi:10.1188/04.onf.269-278 · Cited by 68
Immediate effects of an 8-h advance shift of the rest-activity cycle on 24-h profiles of cortisol
Caufriez, A., Moreno‐Reyes, R., Leproult, R., Vertongen, F., Cauter, E. V., & Copinschi, G. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00525.2001 · Cited by 68
Browning, L. M., Krebs, J. D., & Jebb, S. A. (2004) · Metabolism · doi:10.1016/j.metabol.2004.01.013 · Cited by 63
Ahlberg, K., Ekman, T., & Gaston‐Johansson, F. (2004) · Biological Research For Nursing · doi:10.1177/1099800403259500 · Cited by 60
Ganz, P. A. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.3.182 · Cited by 58
The Phosphodiesterase Type 4 Inhibitor, Rolipram, Enhances Glucocorticoid Receptor Function
Miller, A. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00381-0 · Cited by 57
Self-citationScreening studies for fatigue and laboratory correlates in cancer patients undergoing treatment.
Shafqat, A., Einhorn, L., Hanna, N. H., Sledge, G., Hanna, A., Juliar, B. E., Monahan, P. O., & Bhatia, S. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi267 · Cited by 56
Mj, P. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.21.4180 · Cited by 56
Mj, P. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.191 · Cited by 51
Castellon, S. A., Silverman, D. H. S., & Ganz, P. A. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-5342-0 · Cited by 49
Delayed neurotoxicity of intraventricular interleukin-2: A case report
Meyers, C. A., & Yung, W. K. A. (1993) · Journal of Neuro-Oncology · doi:10.1007/bf01050073 · Cited by 30
Morant, R., Stiefel, F., Berchtold, W., Radziwill, A. J., & Riesen, W. (1993) · Supportive Care in Cancer · doi:10.1007/bf00366904 · Cited by 29
Neurotransmitters, Receptors, Signal Transduction, and Second Messengers in Psychiatric Disorders
Szabo, S. T., Gould, T. D., & Manji, H. K. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585623860.as01 · Cited by 20
MSI and epigenetic changes in colorectal cancers from African Americans
Ashktorab, H., Smoot, D., Fidelia-Lambert, M. N., Carethers, J., & Giardiello, F. M. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.14_suppl.3570 · Cited by 6
Cited by
Cancer-related fatigue—mechanisms, risk factors, and treatments
Bower, J. E. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.127 · Cited by 1,666
Self-citationBreast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180
Cancer-Related Fatigue, Version 2.2015
Berger, A. M., Mooney, K., Alvarez-Perez, A., Breitbart, W. S., Carpenter, K. M., Cella, D., Cleeland, C., Dotan, E., Eisenberger, M. A., Escalante, C. P., et al. (2015) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2015.0122 · Cited by 949
Reciprocal regulation of the neural and innate immune systems
Irwin, M. R., & Cole, S. W. (2011) · Nature Reviews Immunology · doi:10.1038/nri3042 · Cited by 910
“, and documented increased rates of MDD in clinical conditions involving high levels of inflammation (for example, in patients with cancer”
BackgroundSelf-citation
Metadata
- Authors
- Miller, A. H., Ancoli-Israel, S., Bower, J. E., Capuron, L., & Irwin, M. R.
- Venue
- Journal of Clinical Oncology
- Published
- 2008-02-20
- Volume
- 26
- Issue
- 6
- Pages
- 971-982
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2164859678
- Cited by
- 608
- References
- 158
- FWCI
- 9.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.